EGFR TKIs impair lysosome-dependent degradation of SQSTM1 to compromise the effectiveness in lung cancer

Lixian Yang(Zhejiang Provincial People's Hospital), Hongchuan Jin(Sir Run Run Shaw Hospital)
Signal Transduction and Targeted Therapy
July 11, 2019
Cited by 28


Related Papers